Category: New England Journal of Medicine

Interview with Professor Kevin Outterson on the FDA’s guidance on off-label promotion and the move toward clinical trial transparency

July 8th, 2014 in 2014, Kevin Outterson, New England Journal of Medicine, Newsmakers, School of Law 0 comments

Kevin-Outterson-260x300New England Journal of Medicine
Kevin Outterson, School of Law

Listen to audio of expert Kevin Outterson

Clinical Trial Transparency — Antidote to Weaker Off-Label-Promotion Rules?

July 7th, 2014 in 2014, Kevin Outterson, New England Journal of Medicine, Newsmakers, OP-EDs by BU Professors, School of Law 0 comments

Kevin-Outterson-260x300New England Journal of Medicine
By Kevin Outterson, School of Law

This year promises to be an auspicious period for some long-running battles over the dissemination of biomedical research. Some companies seeking more freedom to promote their products have bristled at recent guidance documents from the Food and Drug Administration (FDA) regarding promotion of drugs and devices for off-label uses, claiming that they violate the First Amendment…

View full article by expert Kevin Outterson

Holistic Review — Shaping the Medical Profession One Applicant at a Time

April 11th, 2013 in 2013, New England Journal of Medicine, Newsmakers, OP-EDs by BU Professors, RESEARCH @ BU, Robert Witzburg, School of Medicine 0 comments

WitzburgNew England Journal of Medicine
Co-written by Robert Witzburg, School of Medicine

Modern medicine has been characterized by rapid and accelerating progress in biomedical sciences as the foundation for clinical practice…

View full article

Limiting “Sugary Drinks” to Reduce Obesity — Who Decides?

April 4th, 2013 in 2013, George Annas, New England Journal of Medicine, Newsmakers, OP-EDs by BU Professors, School of Law, School of Public Health 0 comments

mariner_6689_white_65wannas11-150x150New England Journal of Medicine
By Wendy Mariner, School of Public Health, School of Law
By George Annas, School of Public Health

When a judge struck down the New York City Board of Health’s partial ban on selling “sugary drinks” in containers of more than 16 fluid ounces, the reaction was swift…

View full article

Regulating Compounding Pharmacies after NECC

November 13th, 2012 in 2012, Kevin Outterson, New England Journal of Medicine, Newsmakers, OP-EDs by BU Professors, School of Law 0 comments

outterson_white-new_65wNew England Journal of Medicine
By Kevin Outterson, School of Law

Food and Drug Administration (FDA) rules are often forged in crisis…

View article